drugset / Trial / NCT00606203
Dose Milnacipran Prevent Depressive Symptoms in Patients With Acute Stroke?
RandomizedParallel-groupTriple-blindPrevention
Summary
Depression is one of the important psychiatric sequelae after stroke. The prevalence of post stroke depression (PSD) is approximately 20-40%. Depression comorbid with stroke has been found to be associated with increased disability, cognitive function decline, poorer rehabilitation outcome and higher mortality rate.We are going to conduct a trial of prevention of psot stroke depression by prescribing milnacipran in advance.
Timeline
- Start
- 2007-09
- Primary completion
- 2010-09
- Completion
- 2011-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Milnacipran | Other / unclassified | 50 mg | — |